Abstract:
quality of life and emotional regulation among psoriasis patients. The research was carried out on a sample of N=150 (m=58) (f=92) psoriasis patients age 18 and above. A snowball sampling technique was used. Questionnaires were dispatched through google forms. Data was collected online following the COVID-19 safety guidelines. The Coping style scale (Zaman & Ali,2015) was used to assess coping strategies, The Dermatology Life Quality Index (Finlay & Khan,2004) was used to measure the quality of life, and The Emotion Regulation Questionnaire (Kausar & Khan,2014) was used to assess emotional regulation. Reliability coefficients for all scales was high, coping style scale estimates were (PFC=.82 & EFC=.84), ERQ estimates were (ERQ Suppression=.75 & RTQ Reappraisal=.84) and DLQI estimates were (.82). Results revealed a positive significant relationship between ERQ suppression, ERQ reappraisal, and PFC (p=.252** & p=.298**) and a positive relationship between ERQ reappraisal, PFC, and EFC (p=.169* and p=.493**). Findings also revealed a positive relationship between DLQI and PFC (p=.178*) while a negative relationship between DLQI and EFC (p=-.491**). Results also revealed that CS is a predictor of QOL (R2=.303, p<.003 & p<.000), EFC is a nonsignificant predictor of ERQ Suppression (R2= .094, p<.305), PFC is a predictor of ERQ Suppression and CS predicts ERQ Reappraisal (R2 =.094, p<.000). Furthermore, results reveal that CS is a significant predictor of ERQ reappraisal (R2= .275, p<.038 & p<.000). Males use more ERQ Suppression while females use more ERQ Reappraisal. Males use more PFC while females use more EFC. The xx study will help in highlighting the importance of coping strategies on psoriasis patient’s ER and QOL.
